← Back to headlines
Merck and Rivals Reportedly Interested in Inhibrx Cancer Drug
Pharmaceutical giant Merck and other rival companies are reportedly showing interest in acquiring Inhibrx's cancer drug, signaling potential major developments in the oncology market.
22 Apr, 12:37 — 22 Apr, 12:37
Sources
Showing 1 of 1 sources
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
CDC Cancels Publication of COVID Vaccine Effectiveness Study
just now
Fragment of Homer's Iliad Discovered in Egyptian Mummy
just now
Beakless Kea Parrot Becomes Alpha Male Using Unique Technique
10m ago